BIC is processed efficiently to microRNA-155 in Burkitt lymphoma cells

[1]  K. Welte,et al.  Severe congenital neutropenia. , 2009, Hematology/oncology clinics of North America.

[2]  Hugo Naya,et al.  Small RNAs analysis in CLL reveals a deregulation of miRNA expression and novel miRNA candidates of putative relevance in CLL pathogenesis , 2008, Leukemia.

[3]  Erik Flemington,et al.  B-cell Receptor Activation Induces BIC/miR-155 Expression through a Conserved AP-1 Element* , 2008, Journal of Biological Chemistry.

[4]  Wayne Tam,et al.  MicroRNAs in tumorigenesis: a primer. , 2007, The American journal of pathology.

[5]  D. Jong,et al.  Regulation of pri-microRNA BIC transcription and processing in Burkitt lymphoma , 2007, Oncogene.

[6]  W. Tam,et al.  miR‐155/BIC as an oncogenic microRNA , 2006, Genes, chromosomes & cancer.

[7]  E. Haralambieva,et al.  Lack of BIC and microRNA miR-155 expression in primary cases of Burkitt lymphoma. , 2005 .

[8]  A. van den Berg,et al.  BIC and miR‐155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas , 2005, The Journal of pathology.

[9]  I. Touw,et al.  Acute lymphoblastic leukemia in a patient with congenital neutropenia without G-CSF-R and ELA2 mutations , 2005, Leukemia.

[10]  Wayne Tam,et al.  Accumulation of miR-155 and BIC RNA in human B cell lymphomas. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[11]  T. Leblanc,et al.  Screening for G-CSF receptor mutations in patients with secondary myeloid or lymphoid transformation of severe congenital neutropenia. A report from the French neutropenia register , 2004, Leukemia.

[12]  M. Ballmaier,et al.  Incidence of CSF3R mutations in severe congenital neutropenia and relevance for leukemogenesis: Results of a long-term survey. , 2007, Blood.

[13]  Bengt Fadeel,et al.  HAX1 deficiency causes autosomal recessive severe congenital neutropenia (Kostmann disease) , 2007, Nature Genetics.